首页> 外文期刊>Journal of Pain Research >Perioperative Pain Management for Median Sternotomy in a Patient on Chronic Buprenorphine/Naloxone Maintenance Therapy: Avoiding Opioids in Patients at Risk for Relapse
【24h】

Perioperative Pain Management for Median Sternotomy in a Patient on Chronic Buprenorphine/Naloxone Maintenance Therapy: Avoiding Opioids in Patients at Risk for Relapse

机译:慢性丁丙诺啡/纳洛酮维持治疗患者中位数痛苦管理的围手术期疼痛管理:避免复发风险患者的阿片类药物

获取原文
           

摘要

The opioid crisis in the United States has been pandemic. As such, anesthesia providers are frequently faced with patients who have a history of opioid abuse or are currently receiving chronic therapy for such disorders. The chronic administration of medications such as buprenorphine-naloxone can impact the choice of perioperative anesthesia and pain control. Furthermore, the postoperative administration of opioids may lead to relapse in patients with a history of opioid abuse. We present a 26-year-old male with a history of opioid abuse on maintenance therapy with buprenorphine-naloxone, who presented for median sternotomy, cardiopulmonary bypass, and pulmonary valve replacement. The perioperative implications of buprenorphine-naloxone and implementation of multimodal analgesia are discussed, along with options to decrease or eliminate the perioperative use of opioids.
机译:美国阿片类药物危机一直流行。因此,麻醉提供者经常面临具有阿片类药物滥用史或目前用于此类疾病的慢性疗法的患者。慢性施用药物如丁丙诺啡 - 纳洛酮可以影响围手术期麻醉和疼痛对照的选择。此外,阿片类药物的术后施用可能导致阿片类药物滥用史的患者复发。我们展示了一名26岁的男性,患有阿片类药物滥用的历史,培养治疗胸甲甲诺诺诺酮(Buprenorphine-Naloxone),他呈现出胸骨切开术,心肺旁路和肺瓣膜置换。讨论了泛丙啡 - 纳洛酮和实施多模式镇痛的围手术期意义,以及可减少或消除围手术期使用阿片类药物的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号